| 0.0665 0 (0%) | 11-07 13:48 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.1 | 1-year : | 0.11 |
| Resists | First : | 0.08 | Second : | 0.1 |
| Pivot price | 0.07 |
|||
| Supports | First : | 0.06 | Second : | 0.05 |
| MAs | MA(5) : | 0.06 |
MA(20) : | 0.07 |
| MA(100) : | 0.08 |
MA(250) : | 0.21 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 5.2 |
D(3) : | 7.1 |
| RSI | RSI(14): 44.7 |
|||
| 52-week | High : | 0.93 | Low : | 0.03 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SYRA ] has closed above bottom band by 29.1%. Bollinger Bands are 25.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.07 - 0.07 | 0.07 - 0.07 |
| Low: | 0.07 - 0.07 | 0.07 - 0.07 |
| Close: | 0.07 - 0.07 | 0.07 - 0.07 |
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
Tue, 12 Aug 2025
Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions - PR Newswire
Tue, 29 Oct 2024
Syra Health Delivers Third Quarter 2024 Financial Results - Yahoo Finance
Fri, 13 Sep 2024
Syra Health Announces Closing of $2.1 Million Public Offering - Stock Titan
Tue, 23 May 2023
Carmel startup Syra Health files to go public - Inside INdiana Business
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 11 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 34 (%) |
| Held by Institutions | 1.5 (%) |
| Shares Short | 404 (K) |
| Shares Short P.Month | 871 (K) |
| EPS | -0.12 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.14 |
| Profit Margin | -18.1 % |
| Operating Margin | -3.3 % |
| Return on Assets (ttm) | -27.4 % |
| Return on Equity (ttm) | -64.7 % |
| Qtrly Rev. Growth | -1.3 % |
| Gross Profit (p.s.) | 0.21 |
| Sales Per Share | 0.71 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.56 |
| PEG Ratio | 0 |
| Price to Book value | 0.47 |
| Price to Sales | 0.09 |
| Price to Cash Flow | -1.4 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|